• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Signaling mechanisms in neuroendocrine tumors as targets for therapy.神经内分泌肿瘤的信号转导机制作为治疗靶点。
Endocrinol Metab Clin North Am. 2010 Dec;39(4):801-10. doi: 10.1016/j.ecl.2010.08.002.
2
Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.胰腺神经内分泌肿瘤:临床特征、诊断和治疗:进展。
Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):737-53. doi: 10.1016/j.bpg.2012.12.003.
3
Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms.聚焦小细胞肺癌和其他肺神经内分泌肿瘤。
Am Soc Clin Oncol Educ Book. 2023 May;43:e390794. doi: 10.1200/EDBK_390794.
4
[Diagnosis of neuroendocrine tumours in the gastrointestinal tract].[胃肠道神经内分泌肿瘤的诊断]
Ugeskr Laeger. 2010 Oct 25;172(43):2957-60.
5
New molecular aspects in the diagnosis and therapy of neuroendocrine tumors of the gastroenteropancreatic system.
Recent Results Cancer Res. 2000;153:45-60. doi: 10.1007/978-3-642-59587-5_4.
6
Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤的预后和预测生物标志物
JOP. 2013 Mar 10;14(2):155-7. doi: 10.6092/1590-8577/1472.
7
[Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system].[专家对话:肺和胃肠胰系统神经内分泌肿瘤]
Pneumologie. 2012 Jan;66(1):44-8. doi: 10.1055/s-0031-1291478. Epub 2012 Jan 16.
8
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.2014年北欧胃肠胰神经内分泌肿瘤诊断与治疗指南。
Acta Oncol. 2014 Oct;53(10):1284-97. doi: 10.3109/0284186X.2014.941999. Epub 2014 Aug 20.
9
Genes involved in neuroendocrine tumor biology.参与神经内分泌肿瘤生物学过程的基因。
Pituitary. 2006;9(3):165-78. doi: 10.1007/s11102-006-0262-5.
10
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).胃肠胰神经内分泌(包括类癌)肿瘤(NETs)管理指南。
Gut. 2012 Jan;61(1):6-32. doi: 10.1136/gutjnl-2011-300831. Epub 2011 Nov 3.

引用本文的文献

1
Tumor and α-SMA-expressing stromal cells in pancreatic neuroendocrine tumors have a distinct RNA profile depending on tumor grade.胰腺神经内分泌肿瘤中的肿瘤细胞和表达α-平滑肌肌动蛋白(α-SMA)的基质细胞具有取决于肿瘤分级的独特RNA谱。
Mol Oncol. 2025 Mar;19(3):659-681. doi: 10.1002/1878-0261.13727. Epub 2024 Sep 8.
2
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects.神经内分泌肿瘤铂类化疗敏感性相关改变途径概述:优势与前景。
Int J Mol Sci. 2024 Aug 6;25(16):8568. doi: 10.3390/ijms25168568.
3
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons.血脂异常、降脂药物与神经内分泌肿瘤:新的前景。
Endocrine. 2024 Aug;85(2):520-531. doi: 10.1007/s12020-024-03767-7. Epub 2024 Mar 20.
4
Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms.肿瘤异质性以及胃肠胰神经内分泌肿瘤管理中随之而来的实际挑战
Cancers (Basel). 2023 Mar 20;15(6):1861. doi: 10.3390/cancers15061861.
5
Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets.胰腺神经内分泌肿瘤:分子机制与治疗靶点
Cancers (Basel). 2021 Oct 12;13(20):5117. doi: 10.3390/cancers13205117.
6
Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.散发型和遗传性无功能胰腺神经内分泌肿瘤中独特的全基因组甲基化模式。
Cancer. 2019 Apr 15;125(8):1247-1257. doi: 10.1002/cncr.31930. Epub 2019 Jan 8.
7
The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer.Notch信号通路及瘦素-Notch相互作用在胰腺癌中的作用
Medicines (Basel). 2018 Jul 2;5(3):68. doi: 10.3390/medicines5030068.
8
Molecular challenges of neuroendocrine tumors.神经内分泌肿瘤的分子挑战
Oncol Lett. 2018 Mar;15(3):2715-2725. doi: 10.3892/ol.2017.7680. Epub 2017 Dec 21.
9
Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.胃肠胰神经内分泌肿瘤的靶向治疗:临床前策略与未来靶点
Endocr Connect. 2018 Jan;7(1):R1-R25. doi: 10.1530/EC-17-0286. Epub 2017 Nov 16.
10
Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.硫代珊瑚素改变神经内分泌表型并激活 MTC-TT 细胞系中的 Notch 通路。
Cancer Med. 2013 Oct;2(5):734-43. doi: 10.1002/cam4.118. Epub 2013 Sep 17.

本文引用的文献

1
Multi-targeted approach in the treatment of thyroid cancer.甲状腺癌治疗中的多靶点方法。
Minerva Chir. 2010 Feb;65(1):59-69.
2
Neuroendocrine tumors of the pancreas: what's new. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.胰腺神经内分泌肿瘤:新进展。“2010年美国临床肿瘤学会胃肠癌研讨会”亮点。美国佛罗里达州奥兰多。2010年1月22日至24日。
JOP. 2010 Mar 5;11(2):135-8.
3
Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.Notch在甲状腺C细胞发育及甲状腺髓样癌治疗中的作用
Am J Transl Res. 2010 Feb 10;2(1):119-25.
4
Identification of a novel Raf-1 pathway activator that inhibits gastrointestinal carcinoid cell growth.鉴定一种新型 Raf-1 通路激活剂,抑制胃肠道类癌细胞生长。
Mol Cancer Ther. 2010 Feb;9(2):429-37. doi: 10.1158/1535-7163.MCT-09-0718. Epub 2010 Jan 26.
5
Accomplishments in 2008 in the management of gastrointestinal neuroendocrine tumors.2008年胃肠道神经内分泌肿瘤管理方面的成就。
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S62-6.
6
Molecular pathology of differentiated thyroid cancer.分化型甲状腺癌的分子病理学
Q J Nucl Med Mol Imaging. 2009 Oct;53(5):440-53.
7
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.肺类癌细胞中的磷脂酰肌醇3-激酶-Akt信号传导
J Am Coll Surg. 2009 Jul;209(1):82-8. doi: 10.1016/j.jamcollsurg.2009.03.006. Epub 2009 May 1.
8
Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.抑制磷脂酰肌醇3-激酶/蛋白激酶B信号传导可抑制胃肠道类癌肿瘤中的肿瘤细胞增殖和神经内分泌标志物表达。
Ann Surg Oncol. 2009 Oct;16(10):2936-42. doi: 10.1245/s10434-009-0591-5. Epub 2009 Jul 9.
9
Medullary thyroid cancer: molecular biology and novel molecular therapies.甲状腺髓样癌:分子生物学与新型分子治疗方法。
Neuroendocrinology. 2009;90(4):323-48. doi: 10.1159/000220827. Epub 2009 May 25.
10
Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway.陶氏霉素通过激活Raf-1信号通路抑制类癌细胞的生长和神经内分泌激素标志物。
Am J Surg. 2009 Mar;197(3):313-9. doi: 10.1016/j.amjsurg.2008.10.007.

神经内分泌肿瘤的信号转导机制作为治疗靶点。

Signaling mechanisms in neuroendocrine tumors as targets for therapy.

机构信息

Endocrine Surgery Research Laboratories, Department of Surgery, University of Wisconsin Carbone Cancer Center, Madison, WI 53705, USA.

出版信息

Endocrinol Metab Clin North Am. 2010 Dec;39(4):801-10. doi: 10.1016/j.ecl.2010.08.002.

DOI:10.1016/j.ecl.2010.08.002
PMID:21095546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3011942/
Abstract

Although neuroendocrine tumors are rare, the more common types such as gastrointestinal and pancreatic carcinoids, medullary thyroid cancers, and small cell lung cancers have been studied in detail during the last few years. Data published thus far indicate that multiple signaling pathways are involved in these cancers. Recent focus has been on developing novel therapeutics by targeting specific signaling pathways. This article details several of the signaling mechanisms that have been discovered to play a role in the development and progression of neuroendocrine tumors. The therapeutic options developed to address the various pathways, including their specific mechanisms of actions, are also discussed.

摘要

虽然神经内分泌肿瘤比较少见,但是近年来,人们对较为常见的类型(如胃肠道和胰腺神经内分泌癌、甲状腺髓样癌和小细胞肺癌)进行了详细的研究。到目前为止发表的数据表明,多种信号通路参与了这些癌症的发生发展。目前的研究重点是通过针对特定信号通路来开发新的治疗方法。本文详细介绍了几种已发现的在神经内分泌肿瘤的发生和进展中起作用的信号机制。本文还讨论了为解决各种信号通路而开发的治疗选择,包括它们的具体作用机制。